Privitera, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 168
EU - Europa 127
AS - Asia 62
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 360
Nazione #
US - Stati Uniti d'America 168
SE - Svezia 45
SG - Singapore 30
IT - Italia 22
CN - Cina 16
IE - Irlanda 16
DE - Germania 15
ID - Indonesia 9
FR - Francia 8
FI - Finlandia 7
BE - Belgio 4
IR - Iran 4
CZ - Repubblica Ceca 3
CI - Costa d'Avorio 2
IN - India 2
RU - Federazione Russa 2
UA - Ucraina 2
AZ - Azerbaigian 1
CH - Svizzera 1
EU - Europa 1
GB - Regno Unito 1
NL - Olanda 1
Totale 360
Città #
Chandler 55
Singapore 28
Ashburn 23
Dublin 16
New York 14
Jakarta 9
Marseille 7
Bremen 6
Helsinki 6
Princeton 6
Cagliari 5
Boston 4
Brussels 4
Los Angeles 4
Milan 4
Falkenstein 3
San Mateo 3
Abidjan 2
Brdo 2
Fairfield 2
Kish 2
Pavia 2
Pune 2
Rome 2
San Diego 2
Washington 2
Ann Arbor 1
Atlanta 1
Baku 1
Beijing 1
Bellano 1
Boardman 1
Boydton 1
Brno 1
Chicago 1
Corigliano d'Otranto 1
Frankfurt am Main 1
Kashan 1
Lappeenranta 1
London 1
Moscow 1
Nantong 1
Rotterdam 1
Sacramento 1
Seattle 1
Shaoyang 1
Springfield 1
Taranto 1
Wilmington 1
Zurich 1
Totale 239
Nome #
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 65
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 55
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 49
Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer 46
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 42
Predictors and early markers of response to biological therapies in inflammatory bowel diseases 40
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 38
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 22
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 15
Totale 372
Categoria #
all - tutte 2.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 1 0 0 1 5 0
2021/202252 1 0 1 4 0 3 0 5 0 10 13 15
2022/2023152 22 21 14 25 10 11 10 9 27 2 1 0
2023/2024108 4 21 6 9 5 23 7 1 5 4 12 11
2024/202553 1 3 16 5 16 12 0 0 0 0 0 0
Totale 372